Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 October 2025 | Story Tshepo Tsotetsi | Photo Supplied
John Bridger Prof Johan Coetzee Roland Rudd Fiat Lux
From left: John Bridger, Old Boys Association Central Committee Board member; Prof Johan Coetzee; and Roland Rudd, Headmaster of Saint Andrews School; at the St Andrews Speech Day awards ceremony on 16 October.

Prof Johan Coetzee, Head of the Department of Economics and Finance at the University of the Free State (UFS), has been named the recipient of the Fiat Lux Award – the highest honour bestowed by St Andrew’s School in Bloemfontein. 

The award, presented at the annual St Andrews Speech Day awards ceremony on Thursday 16 October, recognises Old Andreans (alumni of the school) who have made exceptional contributions to society through professional excellence and personal integrity.

 

A journey of values, excellence, and lifelong connection

Previous recipients of the Fiat Lux Award include notable figures such as former Nedcor CEO Richard Laubscher, palaeoanthropologist, Apartheid activist, and three-time Nobel Prize nominee Prof Phillip Tobias, former President of the American Chamber of Commerce in South Africa Roger Crawford, and Carte Blanche Executive Producer George Mazarakis.

Prof Coetzee, who matriculated from St Andrew’s in 1995, describes the recognition as deeply humbling. “It is difficult to put into words what this means to me. As an Old Boy of St Andrew’s, it puts the seal of approval on the career path I chose – one that started in the corridors of that school 38 years ago,” he says.

He recalls that his school years shaped both his outlook and his work ethic. “The school taught me the importance of teamwork and resilience. It made me realise early on that life is not all rosy, and that one must maintain a balanced perspective – that is what sets St Andrew’s apart.”

For Prof Coetzee, this honour is not only a personal milestone but also a reflection of the close ties between the UFS and local schools of excellence. “It is extremely important for the UFS to maintain strong links with schools like St Andrew’s, which acts as a feeder for future students and athletes. It’s a win-win situation for both institutions,” he says.

He hopes that his recognition will inspire current learners at St Andrew’s to pursue their goals with perseverance. “I hope that this award awakens the drive in the current crop of pupils at Saints to realise that anything is possible – that your background or the setbacks you face do not define you. Also, and perhaps more importantly, that hard work and persistence does pay off.”

Prof Coetzee’s achievement reflects the UFS’ value of Excellence, exemplifying the university’s commitment to nurturing leaders who embody integrity, dedication, and a lifelong pursuit of learning.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept